Last reviewed · How we verify

NCT03825913

3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma

Terminated NA Last updated 28 August 2020
What this trial tests

NA trial testing Exercise Intervention in Melanoma in 1 participant. Terminated before completion.

Timeline
6 November 2019
Primary endpoint
21 February 2020
21 February 2020

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment1
Start date6 November 2019
Primary completion21 February 2020
Estimated completion21 February 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

18 and older, any sex, with Melanoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our proposed study will focus on addressing the feasibility, safety and benefits of a 3-month exercise intervention among individuals diagnosed with melanoma. The study will be conducted at University of Miami Miller School of Medicine. Eligible participants (n=24) will be randomized into 3 months of wellness education (n=12) or structured exercise (n=12).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise Intervention

Trials testing the same drug.

Other recruiting trials for Melanoma

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03825913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing